Biotechnology - Complera

Filter

Current filters:

Complera

Popular Filters

Merck & Co and Gilead highlight new data at international HIV meeting

16-11-2012

US pharma giant Merck & Co (NYSE: MRK)presented new data at the 11th International Congress on HIV and…

Anti-viralsBiotechnologyCompleraGilead SciencesIsentressMerck & CoPharmaceuticalResearchStribild

Batch of clinical trial results for Gilead's elvitegravir, Complera and cobicistat

25-07-2012

US biotech firm Gilead Sciences (Nasdaq: GILD), the world's biggest producer of HIV treatments, announced…

Anti-viralsBiotechnologycobicistatCompleraelvitegravirGilead SciencesResearch

Back to top